Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study.

The CRP levels of patients at baseline were significantly higher than those before thalidomide treatment ( P = 0.021), and the ESR levels were also higher than those before thalidomide treatment, but this difference did not reach statistical significance ( P = 0.163), which means that patients under the original treatment regimen might not have maintained the inflammatory indicators in the normal ranges.

also in 111,027 other papers